Logo image of HGBL

HERITAGE GLOBAL INC (HGBL) Stock Fundamental Analysis

USA - NASDAQ:HGBL - US42727E1038 - Common Stock

1.52 USD
-0.01 (-0.65%)
Last: 10/15/2025, 3:51:22 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HGBL. HGBL was compared to 237 industry peers in the Capital Markets industry. HGBL has only an average score on both its financial health and profitability. HGBL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HGBL had positive earnings in the past year.
HGBL had a positive operating cash flow in the past year.
In the past 5 years HGBL has always been profitable.
HGBL had a positive operating cash flow in 4 of the past 5 years.
HGBL Yearly Net Income VS EBIT VS OCF VS FCFHGBL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M 15M

1.2 Ratios

With a Return On Assets value of 4.09%, HGBL perfoms like the industry average, outperforming 59.92% of the companies in the same industry.
With a Return On Equity value of 5.46%, HGBL is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
With a decent Return On Invested Capital value of 6.44%, HGBL is doing good in the industry, outperforming 73.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HGBL is in line with the industry average of 7.58%.
Industry RankSector Rank
ROA 4.09%
ROE 5.46%
ROIC 6.44%
ROA(3y)14.77%
ROA(5y)14.4%
ROE(3y)20.15%
ROE(5y)20.41%
ROIC(3y)9.06%
ROIC(5y)7.53%
HGBL Yearly ROA, ROE, ROICHGBL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

Looking at the Profit Margin, with a value of 7.33%, HGBL is doing worse than 63.29% of the companies in the same industry.
HGBL's Profit Margin has declined in the last couple of years.
HGBL has a Operating Margin of 12.89%. This is in the lower half of the industry: HGBL underperforms 66.24% of its industry peers.
In the last couple of years the Operating Margin of HGBL has grown nicely.
With a decent Gross Margin value of 63.52%, HGBL is doing good in the industry, outperforming 73.42% of the companies in the same industry.
HGBL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.89%
PM (TTM) 7.33%
GM 63.52%
OM growth 3Y13.35%
OM growth 5Y10.34%
PM growth 3Y-1.15%
PM growth 5Y-5.18%
GM growth 3Y-1.1%
GM growth 5Y-0.45%
HGBL Yearly Profit, Operating, Gross MarginsHGBL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, HGBL has less shares outstanding
HGBL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HGBL has an improved debt to assets ratio.
HGBL Yearly Shares OutstandingHGBL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HGBL Yearly Total Debt VS Total AssetsHGBL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -1.12, we must say that HGBL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.12, HGBL is doing worse than 82.70% of the companies in the same industry.
HGBL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.06, HGBL belongs to the top of the industry, outperforming 82.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACCN/A
HGBL Yearly LT Debt VS Equity VS FCFHGBL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.05 indicates that HGBL has no problem at all paying its short term obligations.
HGBL's Current ratio of 2.05 is fine compared to the rest of the industry. HGBL outperforms 72.15% of its industry peers.
HGBL has a Quick Ratio of 1.69. This is a normal value and indicates that HGBL is financially healthy and should not expect problems in meeting its short term obligations.
HGBL has a Quick ratio of 1.69. This is in the better half of the industry: HGBL outperforms 68.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.69
HGBL Yearly Current Assets VS Current LiabilitesHGBL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The earnings per share for HGBL have decreased strongly by -66.67% in the last year.
Measured over the past 5 years, HGBL shows a small growth in Earnings Per Share. The EPS has been growing by 1.44% on average per year.
The Revenue for HGBL has decreased by -11.05% in the past year. This is quite bad
HGBL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.63% yearly.
EPS 1Y (TTM)-66.67%
EPS 3Y15.87%
EPS 5Y1.44%
EPS Q2Q%-28.57%
Revenue 1Y (TTM)-11.05%
Revenue growth 3Y20.71%
Revenue growth 5Y11.63%
Sales Q2Q%18.97%

3.2 Future

HGBL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.49% yearly.
HGBL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.66% yearly.
EPS Next Y16.57%
EPS Next 2Y22.21%
EPS Next 3Y15.23%
EPS Next 5Y14.49%
Revenue Next Year16.71%
Revenue Next 2Y10.43%
Revenue Next 3Y6.1%
Revenue Next 5Y5.66%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HGBL Yearly Revenue VS EstimatesHGBL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
HGBL Yearly EPS VS EstimatesHGBL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.1 0.2 0.3

5

4. Valuation

4.1 Price/Earnings Ratio

HGBL is valuated correctly with a Price/Earnings ratio of 15.20.
Compared to the rest of the industry, the Price/Earnings ratio of HGBL is on the same level as its industry peers.
When comparing the Price/Earnings ratio of HGBL to the average of the S&P500 Index (27.49), we can say HGBL is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 7.27, the valuation of HGBL can be described as very cheap.
88.19% of the companies in the same industry are more expensive than HGBL, based on the Price/Forward Earnings ratio.
HGBL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 15.2
Fwd PE 7.27
HGBL Price Earnings VS Forward Price EarningsHGBL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HGBL is valued cheaper than 93.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.48
HGBL Per share dataHGBL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HGBL's earnings are expected to grow with 15.23% in the coming years.
PEG (NY)0.92
PEG (5Y)10.59
EPS Next 2Y22.21%
EPS Next 3Y15.23%

0

5. Dividend

5.1 Amount

HGBL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HERITAGE GLOBAL INC

NASDAQ:HGBL (10/15/2025, 3:51:22 PM)

1.52

-0.01 (-0.65%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners38.73%
Inst Owner Change0%
Ins Owners13.07%
Ins Owner Change-0.08%
Market Cap52.80M
Analysts83.64
Price Target3.63 (138.82%)
Short Float %0.14%
Short Ratio0.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.11%
Min EPS beat(2)-21.57%
Max EPS beat(2)15.34%
EPS beat(4)1
Avg EPS beat(4)-44.55%
Min EPS beat(4)-121.01%
Max EPS beat(4)15.34%
EPS beat(8)2
Avg EPS beat(8)-17.7%
EPS beat(12)6
Avg EPS beat(12)6.86%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)2
Avg Revenue beat(2)12.2%
Min Revenue beat(2)10.82%
Max Revenue beat(2)13.58%
Revenue beat(4)2
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-23.68%
Max Revenue beat(4)13.58%
Revenue beat(8)3
Avg Revenue beat(8)-4.32%
Revenue beat(12)6
Avg Revenue beat(12)3.57%
Revenue beat(16)9
Avg Revenue beat(16)3.89%
PT rev (1m)-3.13%
PT rev (3m)-3.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.56%
EPS NY rev (1m)2.13%
EPS NY rev (3m)3.23%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.62%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.25%
Valuation
Industry RankSector Rank
PE 15.2
Fwd PE 7.27
P/S 1.08
P/FCF N/A
P/OCF 11.71
P/B 0.8
P/tB 0.96
EV/EBITDA 5.48
EPS(TTM)0.1
EY6.58%
EPS(NY)0.21
Fwd EY13.76%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.13
OCFY8.54%
SpS1.41
BVpS1.89
TBVpS1.58
PEG (NY)0.92
PEG (5Y)10.59
Profitability
Industry RankSector Rank
ROA 4.09%
ROE 5.46%
ROCE 8.76%
ROIC 6.44%
ROICexc 8.88%
ROICexgc 11.17%
OM 12.89%
PM (TTM) 7.33%
GM 63.52%
FCFM N/A
ROA(3y)14.77%
ROA(5y)14.4%
ROE(3y)20.15%
ROE(5y)20.41%
ROIC(3y)9.06%
ROIC(5y)7.53%
ROICexc(3y)11.88%
ROICexc(5y)13.37%
ROICexgc(3y)15.54%
ROICexgc(5y)N/A
ROCE(3y)12.33%
ROCE(5y)10.25%
ROICexcg growth 3Y-7.36%
ROICexcg growth 5Y-37.82%
ROICexc growth 3Y8.82%
ROICexc growth 5Y-8.63%
OM growth 3Y13.35%
OM growth 5Y10.34%
PM growth 3Y-1.15%
PM growth 5Y-5.18%
GM growth 3Y-1.1%
GM growth 5Y-0.45%
F-Score6
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 0.6
Cap/Depr 1410.95%
Cap/Sales 15.54%
Interest Coverage -70.11
Cash Conversion 65.86%
Profit Quality N/A
Current Ratio 2.05
Quick Ratio 1.69
Altman-Z -1.12
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)37.97%
Cap/Depr(5y)85.51%
Cap/Sales(3y)0.4%
Cap/Sales(5y)1.36%
Profit Quality(3y)96.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y15.87%
EPS 5Y1.44%
EPS Q2Q%-28.57%
EPS Next Y16.57%
EPS Next 2Y22.21%
EPS Next 3Y15.23%
EPS Next 5Y14.49%
Revenue 1Y (TTM)-11.05%
Revenue growth 3Y20.71%
Revenue growth 5Y11.63%
Sales Q2Q%18.97%
Revenue Next Year16.71%
Revenue Next 2Y10.43%
Revenue Next 3Y6.1%
Revenue Next 5Y5.66%
EBIT growth 1Y-40.08%
EBIT growth 3Y36.82%
EBIT growth 5Y23.17%
EBIT Next Year-6.09%
EBIT Next 3Y-0.09%
EBIT Next 5Y3.92%
FCF growth 1Y-126.63%
FCF growth 3YN/A
FCF growth 5Y62.57%
OCF growth 1Y-62.47%
OCF growth 3YN/A
OCF growth 5Y57.86%